PALOMAR MEDICAL TECHNOLOGIES INC: 10-K filed 2012-03-12
What PALOMAR MEDICAL TECHNOLOGIES INC reported in its annual report filed 2012-03-12 (fiscal FY 2011): 37 published measures, 100 facts as tagged in accession 0000881695-12-000012.
This filing
- Form
- 10-K (annual report)
- Filed
- 2012-03-12
- Fiscal period
- fiscal FY 2011
- Accession
- 0000881695-12-000012 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PALOMAR MEDICAL TECHNOLOGIES INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 178,061,480 | USD | |
| At 2010-12-31 | 159,577,503 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 23,420,287 | USD | |
| At 2010-12-31 | 20,283,835 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 154,641,193 | USD | |
| At 2010-12-31 | 139,293,668 | USD | |
| At 2009-12-31 | 143,627,199 | USD | |
| At 2008-12-31 | 146,805,425 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 63,077,178 | USD | |
| At 2010-12-31 | 55,099,319 | USD | |
| At 2009-12-31 | 81,948,482 | USD | |
| At 2008-12-31 | 122,601,139 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 7,428,429 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -8,774,956 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -10,459,034 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 4,515,173 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -4,203,987 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 10,319,623 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 979,495 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 3,840,846 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 21,016,646 | USD | 365 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 103,436,868 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 63,720,885 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 60,571,211 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 3,022,838 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 267,323 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -5,669,765 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 407,477 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -23,021,012 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -45,291,646 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | -64,352,734 | USD | |
| At 2010-12-31 | -71,781,163 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 18,695,612 | shares | 365 |
| 2010-01-01 to 2010-12-31 | 18,548,548 | shares | 365 |
| 2009-01-01 to 2009-12-31 | 18,094,914 | shares | 365 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 18,942,016 | shares | 365 |
| 2010-01-01 to 2010-12-31 | 18,548,548 | shares | 365 |
| 2009-01-01 to 2009-12-31 | 18,094,914 | shares | 365 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 0.4 | USD/shares | 365 |
| 2010-01-01 to 2010-12-31 | -0.47 | USD/shares | 365 |
| 2009-01-01 to 2009-12-31 | -0.58 | USD/shares | 365 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 0.39 | USD/shares | 365 |
| 2010-01-01 to 2010-12-31 | -0.47 | USD/shares | 365 |
| 2009-01-01 to 2009-12-31 | -0.58 | USD/shares | 365 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 4,105,963 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 302,595 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 4,439,248 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 36,713,578 | USD | |
| At 2010-12-31 | 37,165,306 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 3,640,185 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 3,799,031 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 7,068,273 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 10,737,682 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -9,191,585 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -7,323,720 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 119,846,531 | USD | |
| At 2010-12-31 | 108,342,446 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 20,337,931 | USD | |
| At 2010-12-31 | 17,429,758 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 3,476,030 | USD | |
| At 2010-12-31 | 2,293,096 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 9,853,682 | USD | |
| At 2010-12-31 | 5,349,835 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 0 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 0 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 258,490 | USD | 365 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 21,175,754 | USD | |
| At 2010-12-31 | 13,021,272 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 15,644,338 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 15,457,745 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 14,679,500 | USD | 365 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 219,062,043 | USD | |
| At 2010-12-31 | 211,376,381 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | -263,849 | USD | |
| At 2010-12-31 | -490,806 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 232,594 | USD | |
| At 2010-12-31 | 219,554 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 12,437,921 | USD | |
| At 2010-12-31 | 10,742,581 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 7,655,386 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -8,973,465 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -10,208,888 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 8,727,930 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 14,549,822 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 11,254,199 | USD | 365 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 1,423,233 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 1,313,811 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 612,633 | USD | 365 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -298,826 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 297,644 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 544,119 | USD | 365 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 4,526,311 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 906,885 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -1,943,833 | USD | 365 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 8,126,861 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 1,674,508 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -5,198,413 | USD | 365 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 1,212,223 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -803,238 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -1,068,386 | USD | 365 |
Inspect the source
- Entity
- PALOMAR MEDICAL TECHNOLOGIES INC / CIK 0000881695
- Captured
- SEC response SHA-256
2dd119a4e9049cd3bb87f5900c35e4922ace75e6dcbfef751515742520a8f1cf
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000881695.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))